Our main therapeutic fOCUS

fOCUS Pharmaceuticals is currently in the early stages of research and development of several products that it may potentially submit to the FDA for regulatory approval. Our therapeutic efforts are focused on therapies for Psoriasis, Acne Vulgaris, Actinic Keratoses, Atopic Dermatitis, Cutaneous Ulcers and Onychomycosis (nail fungus).

We are investigating traditional pharmaceutical compounds and biotechnology approaches through our subsidiary fOCUS Biotech to treat diseases of the skin. Our R&D efforts are derived from in-house sources and potential licensing agreements with research and development partners worldwide.